搜尋結果
Council Post: A Paradigm Shift For Healthtech CEOs: Increasing Patient Satisfaction And ...
Forbes· 16 小時前In our hyperconnected world, seamless communication is the norm. Having witnessed the ...
Ohio Regulators Approve First Recreational Marijuana Sales Licenses
Forbes· 16 小時前Ohio marijuana regulators have issued dozens of provisional licenses to sell recreational ...
Doctors must keep prescriptions for Ozempic in check, Danish regulator says
Reuters· 12 小時前, opens new tab Ozempic diabetes drug patients can pick up at one time, the Danish Patient< ...
UK's NHS says hackers have published data stolen in ransomware attack
Reuters· 5 小時前Britain's National Health Service said on Monday that data had been published online ...
Alnylam Shares Soar After Drug Meets Goal in Heart Disease Trial
Bloomberg· 10 小時前... Monday found that Alnylam’s vutrisiran, which is sold as Amvuttra, helped patients with .. ...
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing
Reuters· 3 小時前, opens new tab will spend $4.1 billion to build a U.S. facility to fill injection pens for its ...
Alnylam Pharma Shares Surge 30% After Rare Heart Disease Drug Succeeds
Forbes· 16 小時前Shares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in ...
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
CNBC· 3 小時前Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in ...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 10 小時前G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a ...
5 Startup Opportunities In Anti-Ageing
Forbes· 16 小時前As more and more people around the world have access to better nutrition and healthcare, the ...